← All companies

TNGX

Tango Therapeutics, Inc.

TNGX Nasdaq Pharmaceutical Preparations EDGAR ↗

$27.21

-0.36 -1.31%

Key statistics

from XBRL data in SEC filings

Market cap

$3.94B

Revenue (TTM)

$57.0M

Net income (TTM)

-$107M

EPS (TTM)

$-0.83

P/E ratio

—

Dividend yield

—

Free cash flow

-$140M

Cash

$158M

Total assets

$436M

Gross margin

—

52-week range

$6.21 – $34.39

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change Jun 23, 2026 8-K Entered a material agreement Jun 10, 2026 8-K Regulation FD disclosure; Other events Jun 8, 2026 8-K Shareholder vote results Jun 4, 2026 8-K Results of operations (earnings release); Director or officer change May 13, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 8-K Director or officer change May 8, 2026 8-K Director or officer change; Regulation FD disclosure Apr 15, 2026 8-K Results of operations (earnings release) Mar 5, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Results of operations (earnings release); Director or officer change; Regulation FD disclosure Jan 8, 2026 8-K Director or officer change Jan 5, 2026 8-K Entered a material agreement; Terminated a material agreement Nov 21, 2025 8-K Results of operations (earnings release) Nov 4, 2025 10-Q Quarter ended 2025-09-30 Nov 4, 2025 8-K Entered a material agreement; Unregistered sale of equity Oct 24, 2025 8-K Results of operations (earnings release); Other events Oct 23, 2025 8-K Director or officer change Aug 25, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Results of operations (earnings release) May 12, 2025 10-K Fiscal year ended 2024-12-31 Feb 27, 2025 8-K Results of operations (earnings release) Feb 27, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Jan 13, 2025 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release); Other events Nov 6, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release) Aug 7, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 6, 2024 8-K Regulation FD disclosure; Other events May 23, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Mar 18, 2024 8-K Results of operations (earnings release) Mar 18, 2024 8-K Results of operations (earnings release) Feb 7, 2024 10-Q Quarter ended 2023-09-30 Nov 8, 2023 8-K Results of operations (earnings release) Nov 8, 2023 8-K Director or officer change Aug 30, 2023